← Open Payments lookup

ANDREA GOULBOURNE-SMITH: Open Payments

NPI 1003397944 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$882 in 36 payments from 11 companies in 2025. Trend: 2023 $1,090 · 2024 $641 · 2025 $882

Food & beverage: $882
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$232
Indivior Inc.6$169
Takeda Pharmaceuticals U.S.A., Inc.4$88
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$83
Teva Pharmaceuticals USA, Inc.3$68
Janssen Pharmaceuticals, Inc2$61
Axsome Therapeutics, Inc.3$58
Otsuka America Pharmaceutical, Inc.2$50
Almatica Pharma LLC2$34
Braeburn Inc.1$23

Products named: INGREZZA, SUBLOCADE, TRINTELLIX, CAPLYTA, INVEGA SUSTENNA, UZEDY, Auvelity, LOREEV XR.

Industry payments across FL — which companies pay providers there.